Cross-institution positioning
Aug 10, 2026Accumulation leaning. 2 accumulating, 1 reducing, 2 exited across 5 comparable institutions.
Source: Schedule 13 researchREPL Institutional Ownership
Replimune Group, Inc.
Latest stored close $13.42 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
58/100
7 tracked · 5 comparable
Latest filing
Aug 10, 2026
Positive breadth
4 positive · 3 negative
Recent close
$13.42
Research confidence
Medium
Institutional Research 66/100 · 2 accumulating · 3 reducing / exited
Ownership history
Reported ownership % history
Latest filing Aug 10, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating2
Newly reported2
Reducing / exited
3
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 58/100
Confidence:Medium
Why this signal
- 2 tracked institutions accumulating versus 3 reducing/exited.
- 1 tracked institution recently reversed from reducing to accumulating.
- Latest comparable Form 13F activity is net positive across tracked managers.
Conflicting evidence
- Institutions are bullish while recent insider P/S activity leans bearish.
Institutional
70/100
Insiders
27/100
Fundamentals
50/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Aug 20, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 5 sales by 4 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 16, 20268 non-amendment material events in the last 90 days; 2 capital-related filing/events; Latest classified evidence: Charter or bylaw change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 14, 2026Net income +19.5% YoY; Free cash flow -42.0% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 78% through its reported 52-week range; +129.8% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Initial Schedule 13G from Goldman Sachs Group.
Filed Aug 10, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Aug 10, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
State Street
Filed Aug 7, 2026
Direction locked
BlackRock
Filed Jan 26, 2024
Direction locked
Goldman Sachs Group
Filed Aug 10, 2026
Direction locked
Fidelity / FMR
Filed Feb 9, 2022
Direction locked
T. Rowe Price Associates
Filed May 7, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
State Street
Filed Aug 7, 2026
BlackRock
Filed Jan 26, 2024
Goldman Sachs Group
Filed Aug 10, 2026
Fidelity / FMR
Filed Feb 9, 2022
T. Rowe Price Associates
Filed May 7, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales11 reporting owner(s)
90-day purchase breadth0
90-day sale breadth4Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Astley-Sparke Philip | GGift | Common Stock | 50.0K | $0.00 | Direct | Aug 24, 2026 |
| Aug 17, 2026 | Hill Emily Luisa | SOpen-market or private sale | Common Stock | 9.3K | $14.28 | Direct | Aug 19, 2026 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP, Baker Bros. Advisors (GP) LLC, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN | POpen-market or private purchase · derivative | 2026 $0.0001 Prefunded Warrants | 2.6M | $12.06 | Indirect | Aug 11, 2026 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP, Baker Bros. Advisors (GP) LLC, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN | POpen-market or private purchase · derivative | 2026 $0.0001 Prefunded Warrants | 126.4K | $12.06 | Indirect | Aug 11, 2026 |
| Aug 10, 2026 | Patel Sushil | SOpen-market or private sale | Common Stock | 39.3K | $12.97 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Hill Emily Luisa | SOpen-market or private sale | Common Stock | 11.4K | $12.97 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Xynos Konstantinos | SOpen-market or private sale | Common Stock | 11.4K | $12.97 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Schwendenman Andrew | SOpen-market or private sale | Common Stock | 7.6K | $12.97 | Direct | Aug 12, 2026 |
| Jun 1, 2026 | Sarchi Christopher | SOpen-market or private sale | Common Stock | 12.0K | $9.24 | Direct | Jun 3, 2026 |
| May 18, 2026 | Xynos Konstantinos | SOpen-market or private sale | Common Stock | 14.0K | $5.08 | Direct | May 20, 2026 |
| May 18, 2026 | Schwendenman Andrew | SOpen-market or private sale | Common Stock | 7.9K | $5.08 | Direct | May 20, 2026 |
| May 18, 2026 | Sarchi Christopher | SOpen-market or private sale | Common Stock | 8.6K | $5.08 | Direct | May 20, 2026 |
| May 18, 2026 | Astley-Sparke Philip | SOpen-market or private sale | Common Stock | 17.7K | $5.08 | Direct | May 20, 2026 |
| May 18, 2026 | Patel Sushil | SOpen-market or private sale | Common Stock | 37.3K | $5.08 | Direct | May 20, 2026 |
| May 18, 2026 | Hill Emily Luisa | SOpen-market or private sale | Common Stock | 7.8K | $5.08 | Direct | May 20, 2026 |
| Apr 2, 2026 | Sarchi Christopher | SOpen-market or private sale | Common Stock | 6.5K | $8.01 | Direct | Apr 6, 2026 |
| Apr 1, 2026 | BAKER BROS. ADVISORS LP, Baker Bros. Advisors (GP) LLC, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy)uy) | 44.5K | $0.00 | Indirect | Apr 7, 2026 |
| Apr 1, 2026 | BAKER BROS. ADVISORS LP, Baker Bros. Advisors (GP) LLC, 667, L.P., Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN | AGrant, award, or other acquisition · derivative | Non-Qualified Stock Option (right to buy)uy) | 44.5K | $0.00 | Indirect | Apr 7, 2026 |
| Apr 1, 2026 | Sarchi Christopher | AGrant, award, or other acquisition · derivative | Employee Stock Option (right to buy) | 75.0K | $0.00 | Direct | Apr 7, 2026 |
| Apr 1, 2026 | Sarchi Christopher | AGrant, award, or other acquisition | Common Stock | 50.0K | $0.00 | Direct | Apr 7, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events1
90-day capital-related2
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 16, 2026 | 8-K | 5.03, 5.07, 9.01 | Charter or bylaw change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Aug 14, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| Aug 14, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 11, 2026 | 8-K/AAmendment | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 10, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 10, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| Aug 7, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jul 31, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jul 30, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 24, 2026 | S-3/AAmendment | — | Shelf securities registration | Capital-related | Filing |
| Jun 29, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Operating income
$-68.2M
Q1 2027
+24.5% YoY 10-Q filed Aug 14, 2026
Net income
$-69.8M
Q1 2027
+19.5% YoY 10-Q filed Aug 14, 2026
Diluted EPS
$-0.72
Q1 2027
+24.2% YoY 10-Q filed Aug 14, 2026
Operating cash flow
$-75.7M
Q1 2027
+1.7% YoY 10-Q filed Aug 14, 2026
Free cash flow
$-49.0M
Q1 2025
-42.0% YoY 10-Q filed Aug 8, 2024
Cash & equivalents
$185.4M
As of Jun 30, 2026
+90.4% YoY 10-Q filed Aug 14, 2026
Assets
$252.4M
As of Jun 30, 2026
-46.2% YoY 10-Q filed Aug 14, 2026
Liabilities
$146.8M
As of Jun 30, 2026
+10.6% YoY 10-Q filed Aug 14, 2026
Stockholders’ equity
$105.6M
As of Jun 30, 2026
-68.6% YoY 10-Q filed Aug 14, 2026
Shares outstanding
94.2M
As of Aug 11, 2026
+20.7% YoY 10-Q filed Aug 14, 2026
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$13.03
View live quote ↗
52-week low
$1.50
Apr 13, 2026
52-week high
$16.33
Sep 2, 2026
Below 52-week high
20.2%
1W return
-11.8%
1M return
-13.0%
3M return
+45.4%
6M return
+82.5%
YTD return
+34.1%
1Y return
+129.8%
30-day volatility
77.7%
90-day volatility
202.7%
1Y max drawdown
-84.2%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 28 filing(s) · 25 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Goldman Sachs Group CIK0000886982 | Jun 30, 2026 observed Aug 10, 2026 filed · 41d Initial Schedule 13G | Initial Schedule 13G | 4.4K | 5.30% | $11.07 | $13.67 | $13.42 |
| State Street CIK0000093751 | Jun 30, 2026 observed Aug 7, 2026 filed · 38d Initial Schedule 13G | Initial Schedule 13G | 4.4M +3.3M | 5.30% +3.57 pts | $11.07 | $12.06 | $13.42 |
| T. Rowe Price Associates CIK0000080255 | Apr 30, 2026 observed May 7, 2026 filed · 7d Schedule 13G amendment | Reported reduction | 158.0K -8.1M | 12.00% 0.00 pts | $2.57 | $3.34 | $13.42 |
Explore more institutional activity
Related research
Compare REPL with other securities showing similar institutional activity or recent accumulation across several tracked institutions.